Literature DB >> 16145154

Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in Central African Republic.

Renan Duprez1, Eric Kassa-Kelembho, Sabine Plancoulaine, Josette Brière, Mireille Fossi, Léon Kobangue, Pierre Minsart, Michel Huerre, Antoine Gessain.   

Abstract

Epidemic Kaposi's sarcoma (KS) is one of the most frequent types of cancer in several African countries; however, very few data are available on human herpesvirus 8 (HHV-8) markers in KS patients from Central Africa. In a series of 36 AIDS-KS cases from Central African Republic, we showed, using a real-time PCR quantitative assay, the high frequency (82%) of detectable HHV-8 DNA in peripheral blood mononuclear cells (PBMCs). We also found that the level of antibodies directed against lytic or latent HHV-8 antigens is not correlated to the amount of HHV-8 viral load in the PBMCs, and finally, we demonstrated a much higher viral load in tumoral skin lesions (6.07 log copies/mug DNA) than in unaffected skin (2.93 log copies/mug DNA) or in PBMCs (2.55 log copies/mug DNA).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145154      PMCID: PMC1234088          DOI: 10.1128/JCM.43.9.4840-4843.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  HHV-8 subtypes in South Africa: identification of a case suggesting a novel B variant.

Authors:  Florette K Treurnicht; Susan Engelbrecht; Maureen B Taylor; Johan W Schneider; Estrelita Janse van Rensburg
Journal:  J Med Virol       Date:  2002-02       Impact factor: 2.327

2.  Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.

Authors:  G Boivin; A Gaudreau; J P Routy
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

Review 3.  Kaposi's sarcoma in South Africa.

Authors:  F Sitas; R Newton
Journal:  J Natl Cancer Inst Monogr       Date:  2001

Review 4.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay.

Authors:  F Lallemand; N Desire; W Rozenbaum; J C Nicolas; V Marechal
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Molecular epidemiology of human herpesvirus 8 in africa: both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespread.

Authors:  V Lacoste; J G Judde; J Brière; M Tulliez; B Garin; E Kassa-Kelembho; J Morvan; P Couppié; E Clyti; J Forteza Vila; B Rio; A Delmer; P Mauclère; A Gessain
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

7.  Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage.

Authors:  T B Campbell; M Borok; L Gwanzura; S MaWhinney; I E White; B Ndemera; I Gudza; L Fitzpatrick; R T Schooley
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

8.  Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area.

Authors:  Sabine Plancoulaine; Laurent Abel; David Trégouët; Renan Duprez; Monique van Beveren; Patricia Tortevoye; Alain Froment; Antoine Gessain
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

9.  High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population.

Authors:  Sabine Plancoulaine; Laurent Abel; Monique van Beveren; Antoine Gessain
Journal:  J Natl Cancer Inst       Date:  2002-09-04       Impact factor: 13.506

Review 10.  Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy.

Authors:  Ulrich R Hengge; Thomas Ruzicka; Stephen K Tyring; Martin Stuschke; Michael Roggendorf; Robert A Schwartz; Siegfried Seeber
Journal:  Lancet Infect Dis       Date:  2002-05       Impact factor: 25.071

View more
  17 in total

Review 1.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

Review 2.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

3.  FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Authors:  Ruoyun Gao; Tingting Li; Brandon Tan; Suzane Ramos da Silva; Jae U Jung; Pinghui Feng; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.

Authors:  Fan Cheng; Tanvee Vinod Sawant; Ke Lan; Chun Lu; Jae U Jung; Shou-Jiang Gao
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

5.  Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Laura A Adang; Christopher H Parsons; Dean H Kedes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions.

Authors:  Martin M Nsubuga; Robert J Biggar; Susan Combs; Vickie Marshall; Georgina Mbisa; Fred Kambugu; Meghna Mehta; Benon Biryahwaho; Charles S Rabkin; Denise Whitby; Sam M Mbulaiteye
Journal:  Cancer Lett       Date:  2008-01-30       Impact factor: 8.679

7.  Kaposi sarcoma in an patient with atopic dermatitis treated with ciclosporin.

Authors:  Dmitri Wall; Mairín McMenamin; Deirdre O'Mahony; Alan D Irvine
Journal:  BMJ Case Rep       Date:  2013-11-21

8.  Association of NFκB and related-cytokines with the viral load and development of antibodies against HHV-8 in people living with HIV/AIDS.

Authors:  Juliana Prado Gonçales; Thaísa Regina Rocha Lopes; Virginia Maria Barros de Lorena; Melayne Rocha Aciole; José Valter Joaquim Silva Júnior; Tania Regina Tozetto-Mendoza; Paulo Henrique Braz-Silva; Maria Rosangela Cunha Duarte Coêlho
Journal:  Med Microbiol Immunol       Date:  2019-10-04       Impact factor: 3.402

9.  KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.

Authors:  Nader Kim El-Mallawany; Parth S Mehta; William Kamiyango; Jimmy Villiera; Erin C Peckham-Gregory; Coxcilly Kampani; Robert Krysiak; Marcia K Sanders; Carolina Caro-Vegas; Anthony B Eason; Saeed Ahmed; Gordon E Schutze; Stephen C Martin; Peter N Kazembe; Michael E Scheurer; Dirk P Dittmer
Journal:  Int J Cancer       Date:  2018-10-31       Impact factor: 7.396

10.  Association Between Immunoglobulin E Levels and Kaposi Sarcoma in African Adults With Human Immunodeficiency Virus Infection.

Authors:  Helen Byakwaga; Arturo Barbachano-Guerrero; Dongliang Wang; Shane McAllister; Kamal Naphri; Miriam Laker-Oketta; Conrad Muzoora; Peter W Hunt; Jeffrey Martin; Christine A King
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.